Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kirkby S et al. – While appropriate anti–infective therapy reduces bacterial density in the airways and may result in clinical improvement, true eradication of airway infection is seldom achieved except for early–stage infections. This review summarizes current approaches for acute and chronic anti–infective therapy in cystic fibrosis.

Related Articles

Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09    Relevance Score: 69%

Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09    Relevance Score: 69%

Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09    Relevance Score: 69%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09    Relevance Score: 69%

Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation
European Respiratory Journal, 10/23/09    Relevance Score: 68%

Today in Antimicrobials...keeping you current

Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities
Phytotherapy Research, 12/09/09

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
The Lancet - Early Online Publication, 12/08/09

Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address